Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury

Summary

The purpose of this study is to see if the treatment of severely brain injured patients with darbepoetin (a long acting form of erythropoietin) will be safe, and will reduce brain damage by decreasing harmful levels of chemicals in the brain.

Timeline

Start

2006-11

Primary completion

2009-12

Completion

2009-12

Drugs

Indications